NHC
National Healthcare CorpPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Assisted living communities | 26 | Q1 2026 | — |
| Assisted living units | 1,413 | Q1 2026 | — |
| Homecare agencies | 34 | Q1 2026 | — |
| Hospice agencies | 33 | Q1 2026 | — |
| Independent living units | 777 | Q1 2026 | — |
| Skilled nursing beds | 10,323 | Q1 2026 | — |
| Skilled nursing facilities | 80 | Q1 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHC
this stock
National Healthcare Corp
|
$3.31B | +55.1% | +5.1% | 26.9 | 3.5% |
|
HCA
HCA Healthcare, Inc.
|
$93.86B | -9.2% | +7.1% | 14.6 | 2.4% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.09B | -13.0% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$17.76B | +5.1% | -2.3% | 10.7 | 4.7% |
|
DVA
Davita Inc.
|
$15.04B | +106.2% | +6.5% | 21.9 | 7.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHC | +0.2% | +12.8% | +56.7% | +0.2% | +55.1% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -0.7% | +11.4% | +49.2% | +0.1% | +45.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.